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Objective: To assess the relationship between being beta globin gene carrier and developing insulin resistance.
Methods: This study was conducted on 164 subjects including 82 healthy ones and 82 patients with beta
thalassemia minor (microcytosis (MCV <80 fl) and hypochromia (MCH <25 pg) and HbA2 ≥ 3.5% using HPLC).
Fasting blood glucose (FBS) values of 100–125 mg/dl were considered as impaired fasting glucose, and above
125 mg/dl as diabetes mellitus. Two hours After 75 gram glucose load(GTT), blood sugar level of 140–199 mg/dl
was considered as impaired glucose tolerance and above 199 mg/dl as diabetes mellitus. Insulin resistance was
diagnosed based on homeostasis model assessment method (HOMA).
Results: According to FBS and BS2hPG values, the percentages of diabetes mellitus, pre diabetes, and normal
glucose tolerance in case group was 8.5%, 9.8% and 81.7%, respectively. There was no case of diabetes mellitus in
control group and 6.1% of this group were pre diabetic and 93.9% of them had normal glucose tolerance test
(P = 0.02). Relative risk for diabetes mellitus and insulin resistance in the cases with minor thalassemia was
2 (95% CI: 1.8-2.5) and 2.02 (95% CI: 1.7-2.4), respectively.
Conclusion: The risk of developing diabetes and insulin resistance in patients with thalassemia minor is two times
greater than the general population. Considering the high serum levels of CRP in these cases, the inflammation
noted in liver cells could be considered as the underlying cause of insulin resistance, impaired glucose tolerance
and diabetes in these patients.
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Insulin resistance is a common problem in patients with
different types of hemoglobinopathies including beta
thalassemia major. Excessive iron deposition in the pan-
creas and liver of patients suffering from thalassemia
major as well as insulin resistance has been described
[1]. It is believed that the increase in iron overload may
damage the pancreatic β cells [2]. Increased iron turn-
over, similarly, may damage liver, contributing to oxida-
tive stress and insulin resistance [3]. The reported
prevalence of impaired glucose tolerance and diabetes
mellitus in thalassemia major is up to 24% and 26%
respectively and it is believed that insulin resistance
can be occurred in these patients before the onset of
glucose intolerance or diabetes mellitus [4]. Insulin* Correspondence: kashi_zahra@yahoo.com
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reproduction in any medium, provided the orresistance in beta thalassemia minor (carrier state) has
been demonstrated as well [4].
Considering high number of complications associated
with insulin resistance and impaired glucose metabolism,
the present study was designed to evaluate the preva-
lence of these metabolic disorders in patients with beta
thalassemia minor.Materials and methods
After being approved by the Ethical Board of Mazan-
daran University of Medical Sciences, Sari, Iran this study
was conducted on 82 individuals with beta thalassemia
minor and 82 healthy subjects as control group[accord-
ing to P1=6% (prevalence of IGT in normal population),
P2=14% (prevalence of IGT in beta thalassemia minor),
d2=10% , Z1-β ,Z1- α/2=1.96]. The diagnosis of beta thal-
assemia minor was based on the detection of hemoglobin
(Hgb) A2 > 3.5% by column chromatography (Spain biotd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Demographic findings of the subjects with beta
thalassemia minor regarding demographic data, Sari,
Iran, 2010
Controls Cases P value
(N = 82) (N= 82)
Mean ± SD Mean ± SD
Age (year) 39.5±8.7 39.7±8.8 0.8
Weight(kg) 67.4±8.5 66.4±8.4 0.4
Height(meter) 170.1±7.7 169.3±7.5 0.5
BMI(kg/m2) 22.9±1.4 22.7±1.4 0.4
Systolic blood pressure(mmHg) 109±4.9 110±4.9 0.6
Diastolic blood pressure(mmHg) 67±4.9 68±5.4 0.8
Waist(cm) Male 83±2 83±2.2 0.8
Female 77±1.3 76±1.8 0.8
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(High-performance liquid chromatography) and cellulose
acetate gel.
Subjects in the two groups were matched in terms of
body mass index (BMI) and family history of diabetes
mellitus. Age range was from 20 to 60 years of age.
Blood pressure values were normal (having diastolic
blood pressure < 80 mmHg and systolic blood pressure <
120 mmHg) [5].
Exclusion criteria consisted of history of kidney, liver
and heart disease, history of diabetes, receiving medica-
tions which affect carbohydrate metabolism (such as
corticostroids,cyclosporin,closapin) and waist circumfer-
ence (WC) more than 102 cm in men and more than
88 cm in women [6].
Anthropometric measurements including weight and
height were obtained with light clothing and without
shoes by trained technicians following international
guidelines. The height (to the nearest 0.1 cm) and weight
(to the nearest 0.1 kg) were measured using a stedi-
ometer and a digital scale (Micro life ws80, Switzerland),
respectively. The BMI was calculated as the body weight
divided by the height squared (Kg/m2). WC was mea-
sured using a non-elastic flexible anthropometric tape
(to the nearest 0.1 cm) in the standing position. The tape
was applied horizontally midway between the lowest rib
margin and the iliac crest.
A fasting blood sample (FBS) was taken from all the
participants. Serum FBS was analyzed by enzymatic
calorimetric method using glucose kit of Parsazmoon
Co, Iran. AST (Aspartate aminotransferase) and ALT
(Alanine aminotransferase) were measured by calorimetric
method using Biosystem kit, Spain and Hitachi917,
Germany. High sensitive C-reactive protein (hs-CRP)
was measured by imminotorbidometry assay by Pars
Azmoon kit, England, using Hitachi917 machine Germany.
ELISA test with Hitachi auto analizer using Monobind kit,
USA was used to assess serum insulin levels. A standard
oral glucose tolerance test (OGTT) was performed in all
subjects.
Individuals with abnormal FBS (FBS ≥100) and/or
abnormal OGTT (blood sugar 2 hours post-prandial
(BS 2hpp) ≥140) were re-tested. FBS values below
100 mg/dl were considered as normal, 100–125 mg/dl
as impaired fasting glucose, and above 125 as diabetes.
BS 2hpp below 140 mg/dl was considered as normal,
140–199 mg/dl as impaired glucose tolerance and above
199 as diabetes [7].
Insulin resistance was calculated using HOMA-IR
(homeostasis model assessment method) [8].
HOMAIR ¼ Fasting plasma insulin mIU=L
 Fasting Plasma Glucose mmol=l22:5Considering HOMA-IR values, the studied population
was divided into three groups:
1. (Insulin Sensitive) HOMA-IR < 2.24
2. (Intermediate) 2.24 ≤ HOMA-IR ≤ 3.59
3. (Insulin Resistance) HOMA-IR > 3.59
The student t-test and chi-squared test were used to
compare demographic data between the two groups.
Relative Risk was measured to test the risk of diabetes
and insulin resistance in two groups. P value less than
0.05 was considered statistically significant.Results
In patient group, 53 cases (64.6%) were female and 29
(35.4%) were male. In control group 38 subjects (46.3%)
were male and 44 (53.7%) were female (P = 0.1). Other
demographic data are outlined in Table 1: According to
FBS and BS2hPG values, the percentages of cases with
diabetes mellitus, impaired fasting glucose, and normal
glucose tolerance were 8.5%, 9.8% and 81.7%, respect-
ively. There was no case of diabetes mellitus in control
group and 6.1% of subjects had impaired fasting glucose
and 93.9% of them were normal glucose tolerance test.
(P = 0.02).
According to FBS and BS2hPG values, the percentages
of cases with diabetes mellitus, impaired fasting glucose,
and impaired glucose tolerance were 7.3%, 11% and
81.7%, respectively. There was no case of diabetes melli-
tus in control group and 7.3% of subjects had impaired
fasting glucose or impaired glucose tolerance. (P = 0.02).
AST and hs-CRP values were also similarly higher
among the cases (Table 2). There was, however, no sig-
nificant difference between mean ALT, fasting insulin
and HOMA-IR levels between the two groups .Fasting
insulin level was 6.5± 5.3 and 5.9±2.0 in case and control
group respectively.
Table 2 Laboratory values of liver enzymes, CRP, fasting
insulin, HOMA-IR in each group
Controls Cases P value
(N = 82) (N= 82)
Mean ± SD Mean ± SD
AST (IU/L) 20.9 ± 7.3 23.6 ± 8.1 0.03
ALT (IU/L) 15.5 ± 7.5 18.3 ± 12.8 0.09
CRP (mg/L) 2.97 ± 1 3.9 ± 3.2 0.01
Fasting serum insulin (μIU/ml) 5.9 ± 2 6.5 ± 5.3 0.4
HOMA-IR 1.1 ± 0.4 1.2 ± 0.4 0.7
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were 2 (CI 95%: 1.8-2.5) and 2.025 (CI 95%: 1.7-2.4)
respectively.
Discussion
In line with previous studies, our findings revealed that
the relative risk of developing diabetes mellitus and insu-
lin resistance in patients with beta thalassemia minor is
two times higher than the general population. Tang et al.
reported that thalassemia minor patients with normal
glucose tolerance have higher fasting insulin levels and
insulin resistance (HOMA-IR) than the healthy controls
matched for age, gender and BMI [4]. In another study
Alhezmy et al. reported that 6 percent of thalassemia
major patients and only 2 percent of the kids with thal-
assemia minor or no hemoglobinopathy were diagnosed
with diabetes mellitus. The prevalence of impaired glu-
cose tolerance was, similarly, higher in patients with
thalassemia major compared to those suffering from
thalassemia minor and healthy subjects. In this study,
subjects were not matched in terms of BMI and family
history of diabetes; both of which play an important role
in the development of diabetes and insulin resistance [9].
Corroborating previous studies, our research reported
significantly higher CRP levels in thalassemia minor
patients [4]. This finding can explain the higher preva-
lence of insulin resistance in these patients [10]. Mean
AST and ALT levels were also higher in this group of
patients [11]. The correlation between ALT levels and
insulin resistance has been reported in other studies
[12-15]. Berget et al. while studying a group of adoles-
cents, pointed out that any increase in ALT levels, even
when it is within the normal range, lowers the sensi-
tivity of the cells to insulin, contributing to impaired
glucose tolerance and increased levels of free fatty
acids and triglycerides [11]. In another study in Native
American adults (Pima Indians), ALT was reported as a
predictor of type II diabetes [15]. Considering the higher
serum levels of liver enzymes and hs-CRP in thalassemia
minor patients, the inflammation of liver cells could beaccounted for the underlying cause of insulin resistance
and impaired glucose tolerance in these patients [4]. In
other words, liver inflammation and increased oxidative
stress secondary to microcytic erythrocytes hemolysis is
the main reason contributing to higher prevalence of
diabetes in thalassemia minor patients. According to
this concept Noetzli et al. in their study showed that
Pancreatic iron overload and diabetes mellitus (DM) are
common in thalassemia major patients and iron depos-
ition in pancreas is the strongest predictor of beta cell
toxicity and total body iron burden, age, and body
habitus also influence glucose regulation too [16].
The certain limitation of our study was that serum
level of ferritin a marker of liver inflammation was not
measured though we measured the CRP another marker
of inflammation.
Conclusion
The present study revealed that similar to thalassemia
major sufferers, the prevalence of insulin resistance and
diabetes is higher in patients with thalassemia minor
than the general population. Considering the high preva-
lence of thalassemia minor in our country and the fact
that impaired glucose metabolism is associated with
multiple complications, it is recommended to screen
thalassemia minor patients for glucose tolerance at a
younger age. Further studies are also required to detect
other mechanisms contributing to insulin resistance in
these patients.
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